ICON Completes Acquisition of MediMedia Pharma Solutions
02 Março 2015 - 8:00AM
Business Wire
Extends ICON’s leadership in
commercialisation and market access services and brings new
scientific communications capabilities
ICON plc (NASDAQ:ICLR), a global provider of drug
development solutions and services to the pharmaceutical,
biotechnology and medical device industries, today announced that
it has completed the acquisition of MediMedia Pharma Solutions. The
acquisition brings ICON new scientific communications capabilities
which together with ICON’s existing Commercialisation and Outcomes
practices, creates the industry’s leading integrated market access
solution.
Commenting on the completion of the acquisition, ICON Chief
Executive Officer, Ciaran Murray, said: “Helping customers
establish and communicate the value of their products has become
increasingly important as payers look for evidence linking
efficacy, value and price. MediMedia deepens the expertise and
capabilities of our market-leading commercialisation and outcomes
group and brings outstanding scientific and medical communications
capabilities. We are delighted to welcome them to the ICON
team.”
About ICON plc
ICON plc is a global provider of drug development solutions and
services to the pharmaceutical, biotechnology and medical device
industries. The company specialises in the strategic development,
management and analysis of programs that support clinical
development - from compound selection to Phase I-IV clinical
studies. With headquarters in Dublin, Ireland, ICON currently,
operates from 83 locations in 38 countries and has approximately
10,600 employees.
Further information is available at www.iconplc.com.
About MediMedia Pharma Solutions
MediaMedia Pharma Solutions is a combination of MediMedia
Managed Markets and Complete HealthCare Communications.
MediMedia Managed Markets is a leading provider of strategic
payer-validated market access solutions for the biopharmaceutical
and medical device industries. Their comprehensive approach
includes scientific analysis and assessment, research and insights,
strategic development, tactical development, and program execution.
Complete HealthCare Communications is one of the largest medical
communication agencies and is a pioneer in publication services,
providing strategic consulting, software solutions, and scientific
communications to medical affairs teams for life sciences firms
globally.
Further information is available at
http://www.medimediamanagedmarkets.com and www.thechcgroup.com.
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, S-8 and F-3, which are available on the SEC's
website at http://www.sec.gov.
ICON/ICLR-F
ICON Media ContactWeber ShandwickRebecca Power, +44 (0)
207 067 0866RPower@webershandwick.com
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024